Your browser doesn't support javascript.
loading
Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence.
Sulli, Gabriele; Rommel, Amy; Wang, Xiaojie; Kolar, Matthew J; Puca, Francesca; Saghatelian, Alan; Plikus, Maksim V; Verma, Inder M; Panda, Satchidananda.
Afiliação
  • Sulli G; Regulatory Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA.
  • Rommel A; Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, California 92037, USA.
  • Wang X; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, California 92697, USA.
  • Kolar MJ; Clayton Foundation Laboratories of Peptide Biology, Salk Institute for Biological Studies, La Jolla, California 92037, USA.
  • Puca F; Department of Genomic Medicine, The University of Texas MD, Anderson Cancer Center, Houston, Texas 77030, USA.
  • Saghatelian A; Clayton Foundation Laboratories of Peptide Biology, Salk Institute for Biological Studies, La Jolla, California 92037, USA.
  • Plikus MV; Department of Developmental and Cell Biology, University of California, Irvine, Irvine, California 92697, USA.
  • Verma IM; Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, California 92037, USA.
  • Panda S; Regulatory Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA.
Nature ; 553(7688): 351-355, 2018 01 18.
Article em En | MEDLINE | ID: mdl-29320480

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oncogenes / Membro 1 do Grupo D da Subfamília 1 de Receptores Nucleares / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oncogenes / Membro 1 do Grupo D da Subfamília 1 de Receptores Nucleares / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article